TickerSpark Feed

BIIB Coverage

Every TickerSpark article mentioning BIIB — research reports, earnings, trending movements, and macro context.

2 articles

Biogen (BIIB): Turnaround Gains Traction as Growth Mix Improves

Biogen is no longer just a declining MS story. Q1 2026 showed rising EPS, stronger free cash flow, and growing newer products, but full-year revenue still faces pressure.

May 14, 2026·24 min read

Healthcare Drug Manufacturers - General Biotech

Trending StockBIIB

Biogen Inc. (BIIB) drops 6% after mixed Alzheimer’s data

Biogen Inc. (BIIB) drops sharply after mixed Phase 2 Alzheimer’s trial results for diranersen, also known as BIIB080. The stock fell on heavy volume as investors focused on the missed primary endpoint, even though the study showed encouraging biomarker and cognitive signals and the program may still advance.

May 14, 2026·7 min read

Want a deeper dive on BIIB?

Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.

Generate BIIB Report